MarketLens MarketLens
US: 2026-08-12 NSE: 2026-08-12 2026-08-12
Neutral
Menu

Stock Lookup

Search by symbol or company name, then inspect the chart and stock properties.

US

GANX Gain Therapeutics, Inc.

TradingView As Of 8/12/26
Analyst Data
Refresh analyst earnings estimates and rating summary for this symbol only.
Close
2.1090
Day %
2.88%
RS
N/A
Ind Rank
#51
RS 1D
N/A
RS 1W
N/A
RS 1M
N/A
RS 3M
N/A
RS 6M
N/A
Consensus Rating
Buy
Current Quarter EPS
-0.14
Next Quarter EPS
-0.14
Current Year EPS
-0.63
Next Year EPS
-0.91
ExchangeUS
Market Cap0 B
52W High4.3400
From 52W High-51.41%
Open2.0800
High2.1200
Low2.0100
OptionsNo
ActiveYes
RS TypeFull
RS Date2026-08-11
Bars Available310
Scanner Hits1
Last Scanner Hit2026-08-11

Recent Scanner History

1 matching / 1 total
Reset
Date Scanner RS
2026-08-11 4% Breakout
US_FOUR_PERCENT_BREAKOUT
N/A

Analyst Snapshot

As Of 3/29/26
Consensus Current Quarter EPS Next Quarter EPS Current Year EPS Next Year EPS
Buy -0.14 -0.14 -0.63 -0.91
Based on 5 analysts offering recommendations for 'GANX'.

Quarterly EPS Forecasts

4 rows
Period Consensus EPS High Low Estimates Revisions
Mar 2026 -0.14 -0.13 -0.15 2
0 0
Jun 2026 -0.14 -0.13 -0.14 2
0 0
Sep 2026 -0.14 -0.13 -0.16 2
0 0
Dec 2026 -0.17 -0.13 -0.20 2
0 0

Yearly EPS Forecasts

3 rows
Period Consensus EPS High Low Estimates Revisions
Dec 2026 -0.63 -0.55 -0.72 3
0 0
Dec 2027 -0.91 -0.91 -0.91 1
0 0
Dec 2028 -1.16 -1.16 -1.16 1
0 0